Lidocaini Hydrochloridum Noridem (Lidocaine Hydrochloride Monohydrate)

Lidocaine hydrochloride blocks voltage‑gated sodium channels on neuronal membranes, preventing sodium influx during depolarization. This inhibition stops the generation and propagation of nerve impulses, resulting in a reversible, localized loss of pain sensation without affecting consciousness.

The specific dose of Lidocaini Hydrochloridum Noridem is determined by the prescribing clinician based on the procedure, patient weight, age, and clinical condition. Healthcare professionals calculate the appropriate amount to achieve effective anesthesia while minimizing toxicity.

Safety data for lidocaine hydrochloride in pregnancy and lactation are limited. It should only be used when clearly needed and after a risk‑benefit assessment by the prescriber. Breastfeeding mothers should consult their healthcare provider, as small amounts may be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset (1–3 minutes) and moderate duration (1–2 hours). Compared with agents such as bupivacaine, lidocaine has a shorter duration but a lower risk of cardiotoxicity, making it suitable for shorter procedures and epidural analgesia where quick recovery is desired.

Lidocaini Hydrochloridum Noridem should be stored at room temperature, below 25 °C, in its original sealed container. Protect the solution from direct sunlight, moisture and extreme temperatures to maintain sterility and potency.

The product is supplied as a sterile injectable solution and is administered by a qualified healthcare professional via epidural, intradermal or intramuscular injection, depending on the clinical indication. Proper aseptic technique and dosage calculation are essential for safe use.

Serious adverse events include systemic toxicity leading to seizures, cardiac arrhythmias, and, rarely, methemoglobinemia. These risks increase with high plasma concentrations, accidental intravascular injection, or when combined with other sodium channel blockers. Immediate medical attention is required if severe symptoms develop.

Patients with a known hypersensitivity to lidocaine, other amide‑type local anesthetics, or any component of the formulation should avoid this product. Caution is also advised for individuals with severe hepatic impairment, certain cardiac conduction disorders, or those receiving interacting medications listed under major interactions.